Displacement of WDR5 from Chromatin by a WIN Site Inhibitor with Picomolar Affinity
| Autor: | Bin Lu, J.G. Shaw, Hall, Bin Zhao, Jason Phan, Rocco D. Gogliotti, William P. Tansey, Shaun R. Stauffer, Christopher R. Vakoc, Feng Wang, Scott W. Hiebert, Jing Wang, Erin R. Aho, Kenneth Cheng, April M. Weissmiller, Stephen W. Fesik, Qi Liu, Lance R. Thomas, Joseph Alvarado, Pankaj Acharya, Shelly L. Lorey, Gregory C. Howard, Sabine Wenzel, Audra M. Foshage, Jonathan David Macdonald |
|---|---|
| Rok vydání: | 2019 |
| Předmět: |
Male
0301 basic medicine Biology Ribosome Article General Biochemistry Genetics and Molecular Biology 03 medical and health sciences 0302 clinical medicine Ribosomal protein Cell Line Tumor Gene expression Humans WDR5 Enzyme Inhibitors lcsh:QH301-705.5 Gene health care economics and organizations Binding Sites Drug discovery Intracellular Signaling Peptides and Proteins Small molecule Chromatin Cell biology HEK293 Cells 030104 developmental biology lcsh:Biology (General) Female 030217 neurology & neurosurgery Protein Binding |
| Zdroj: | Cell Reports, Vol 26, Iss 11, Pp 2916-2928.e13 (2019) Cell reports |
| ISSN: | 2211-1247 |
| Popis: | SUMMARY The chromatin-associated protein WDR5 is a promising target for pharmacological inhibition in cancer. Drug discovery efforts center on the blockade of the “WIN site” of WDR5, a well-defined pocket that is amenable to small molecule inhibition. Various cancer contexts have been proposed to be targets for WIN site inhibitors, but a lack of understanding of WDR5 target genes and of the primary effects of WIN site inhibitors hampers their utility. Here, by the discovery of potent WIN site inhibitors, we demonstrate that the WIN site links WDR5 to chromatin at a small cohort of loci, including a specific subset of ribosome protein genes. WIN site inhibitors rapidly displace WDR5 from chromatin and decrease the expression of associated genes, causing translational inhibition, nucleolar stress, and p53 induction. Our studies define a mode by which WDR5 engages chromatin and forecast that WIN site blockade could have utility against multiple cancer types. Graphical Abstract In Brief WDR5 is a chromatin-associated protein and promising anti-cancer target. Aho et al. show that WDR5 controls the expression of ribosome protein genes and describe how small molecule inhibitors of WDR5 displace it from chromatin, causing impeded translation, nucleolar stress, and induction of p53-dependent apoptosis in leukemia cells. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|